Treatment Adherence in Myopia Progression Management: A Monocentric Retrospective Study on Rates and Determinants
Clinical Ophthalmology · 2025-11 · Volume 19 · 4107-4115
DOI: 10.2147/opth.s549320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ophthalmology, 2025-11. Verfasst von Andrea Lembo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Clinic, San Giuseppe Hospital - IRCCS MultiMedica, Milan, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To identify factors influencing good adherence when using different myopia management solutions, including low-dose atropine, defocus spectacle lenses (DIMS), defocus contact lenses, photobiomodulation with low-intensity red light, and combined approaches.
Design
Retrospective, observational, single-center chart review. Patients and Methods: This single center retrospective study analyzed clinical and demographic data of myopic patients younger than 17 years. Exclusion criteria were presence of systemic and ocular pathologies, significant refractive (other than myopia) or binocular vision disorders, and follow-up less than 6 months. Data on age, sex, cycloplegic refraction, myopic progression, type of myopia control treatment, and patient-reported adherence to treatment (categorized as good, fair, poor) was obtained from the medical charts.
Results
We analyzed 177 Caucasian pediatric patients (49.2% female; mean age 11.1 ± 2.78 years); 84.2% reported good adherence to treatment, 6.8% reported moderate adherence, and 9.0% reported poor adherence. In multivariate logistic regression analysis, DIMS spectacle lenses showed the strongest association with adherence (OR = 21.17, p = 0.003), followed by the combined use of DIMS spectacle lenses and atropine (OR = 4.02, p = 0.038). Higher myopia progression in spherical equivalent (SE) (OR = 0.31, p = 0.002), and older age (OR 0.78, p = 0.05) were significantly associated with lower adherence.
Conclusion
These findings suggest that younger age and lower myopia progression are associated with better adherence to treatment. Among treatment options, DIMS spectacle lenses alone or combined with atropine, were the strongest predictors of adherence, while other approaches showed no significant associations. This favors optical-based strategies when adherence is a concern and calls for enhanced counseling strategies in adolescents. Several treatments aim to control myopia progression in children, but they only work if adherence is correctly followed over time. We wanted to learn which options are easier to stick with and which factors influence day-to-day use.This study reviewed records from one Milan hospital for myopic children who used at least one option for myopia control for ≥6 months: low-dose atropine, defocus spectacle lenses, myopia-control soft contact lenses, low-level red-light therapy, or combinations. During last visit, children and families reported how consistently they used the treatment.Overall, 84% reported good adherence (≥ 75%). The highest adherence was seen with defocus spectacles (95.7%) and defocus soft contact lenses (95.0%), followed by defocus glasses + atropine (90.5%) and defocus glasses + contact lenses (81.0%); in contrast, atropine alone (66.7%) and red-light therapy (40.0%) showed lower adherence. Older adolescents struggled more, whereas lower myopia progression was linked to better adherence. In everyday practice, optical options – especially defocus glasses, alone or with atropine – may be the most practical choices when sticking with treatment is a concern. Simple routines and tailored counselling are particularly important for adolescents to support long-term, everyday use. Our findings come from one center and rely on self-reports, so results may not apply to all settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Clinic, San Giuseppe Hospital - IRCCS MultiMedica, Milan, Italy.
- Department of Clinical Sciences and Community Health, Department of Excellence 2023-2027, University of Milan, Milan, Italy.
- Section of Biostatistics, Department of Health Sciences, University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Zitieren
APA
Lembo, A., Curci, A., Villani, E., Schiavetti, I., & Nucci, P. (2025). Treatment Adherence in Myopia Progression Management: A Monocentric Retrospective Study on Rates and Determinants. Clinical Ophthalmology, Volume 19, 4107-4115. https://doi.org/10.2147/opth.s549320
Vancouver
Lembo A, Curci A, Villani E, Schiavetti I, Nucci P. Treatment Adherence in Myopia Progression Management: A Monocentric Retrospective Study on Rates and Determinants. Clinical Ophthalmology. 2025;Volume 19:4107-4115. doi:10.2147/opth.s549320
BibTeX
@article{Lembo2025,
author = {Lembo, Andrea and Curci, Alessandra and Villani, Edoardo and Schiavetti, Irene and Nucci, Paolo},
title = {Treatment Adherence in Myopia Progression Management: A Monocentric Retrospective Study on Rates and Determinants},
journal = {Clinical Ophthalmology},
year = {2025},
volume = {Volume 19},
pages = {4107--4115},
doi = {10.2147/opth.s549320}
}
EUVIMED